VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1673830
Sex: F
Age:
State: PA

Vax Date: 04/18/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 18Apr2021 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia. The patient was allergic to many antibiotics and metals. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), levocetirizine dihydrochloride (XYZAL) and ciclosporin (RESTASIS), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 12:30, the patient experienced uncontrollable bloody nose. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event uncontrollable bloody nose was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; MELATONIN; PROZAC; XYZAL; RESTASIS

Current Illness:

ID: 1673831
Sex: M
Age:
State: CA

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: right foot gout flare up, then approx 2 days later foot was better and then the right knee gout flare up, this stayed for a few days, then two days ago from today, gout flare up in right foot and knee is better.; get gout flare ups but have not had one in a long time/right foot gout flare up then approx 2 days later foot was better and then the right knee gout flare up; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 11Apr2021 at 16:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included gout flare and he did not have one in a long time. The patient had no known allergies to food, medications or other products. The patient did not take any concomitant medications . Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 06:00, the patient experienced right foot gout flared up. Then approximately 2 days later foot was better and then the right knee gout flared up. This stayed for a few days, then two days ago from today, gout flared up in right foot and knee was better. He had not had a gout flare up in a long time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event right foot gout flared , then approximately 2 days later foot was better and then the right knee gout flared up was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673832
Sex: F
Age:
State: CT

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:unknown; Comments: make sure (heart attack) enzymes were not in my blood; Test Name: EKG; Result Unstructured Data: Test Result:unknown; Comments: To rule out Afib

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Vasovagal attack pre-syncope; severe burning sensation from my pubic bone area upto my heart as well as tingling in my limbs; severe burning sensation from my pubic bone area upto my heart as well as tingling in my limbs; stomach discomfort; lack of appetite; dizziness; rapid heartbeat; irregular blood pressure; nausea.; This is a spontaneous report from a contactable consumer or other non hcp (patient) reporting herself. A 59-year-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER2613), via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 15:30 as DOSE 2, SINGLE for covid-19 immunisation (age at vaccination: 59 years). Medical history included no medical conditions, healthy. No allergies. Concomitant medications included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID], colecalciferol (VITAMIN D 3) and elderberry [sambucus nigra] (ELDERBERRY [SAMBUCUS NIGRA]), zinc (ZINC) taken for an unspecified indications, start and stop dates were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Left on 10Mar2021 at 15:30 as DOSE 1, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient stated that, the second dose led to an ambulance ride to the ER from the vaccine site due to severe dizziness, rapid heartbeat, irregular blood pressure and nausea. She spent several hours in the ER experiencing waves of nausea, dizziness and elevated heart rate. she was on a heart monitor and had 2 EKGs. she then experienced a severe burning sensation from my pubic bone area up to my heart as well as tingling in my limbs. Afib was ruled out by an EKG and bloodwork was done to make sure (heart attack) enzymes were not in my blood. She was diagnosed with a Vasovagal attack pre-syncope. Three weeks later she was still experiencing some dizziness. she have been following a holistic regimen to tone my vagal nerve. she had been having a lot of stomach discomfort and lack of appetite. The patent experienced severe dizziness, rapid heartbeat, irregular blood pressure, nausea on 31Mar2021 at 15.30. She then experienced a severe burning sensation from my pubic bone area up to heart as well as tingling in limbs, vasovagal attack pre-syncope, stomach discomfort and lack of appetite on an unspecified date. The patient underwent lab tests and procedures, which included EKG and blood work, results: unknown on an unspecified date, to rule out afib and heart attack. Therapeutic measures taken as a result of events included visit to Emergency room/department or urgent care, IV fluids. The outcome of the events of dizziness, stomach discomfort and lack of appetite was not recovered. The outcome of rest of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D 3; ELDERBERRY [SAMBUCUS NIGRA]; ZINC

Current Illness:

ID: 1673833
Sex: F
Age:
State: ID

Vax Date: 04/14/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Losing much more hair than normal the last 4 days.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced losing much more hair than normal the last 4 days, to the point that the patient must clean the brush 2-3 times while brushing the hair when the patient generally only lost a few strands. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event losing much more hair than normal the last 4 days was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673834
Sex: F
Age:
State: NC

Vax Date: 03/29/2021
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:Temperature that fluctuated between 99-101.2

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe headache; Muscle pain; Joint pain; occasional spasms; Temperature that fluctuated between 99-101.2 for approximately 15 hours; Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally; Very drowsy still after sleeping on and off for over 30 hours.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 51-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD and basal cell nevus syndrome (history of numerous basal cell cx's). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 50 mg daily and naproxen sodium (ALEVE) 1 pill 2 nights before; both from unknown dates for unspecified indications. The patient previously took levofloxacin (LEVAQUIN) and fluorouracil (EFUDEX); both on unknown dates for unspecified indications and experienced drug allergy. On an unknown date in 2021, the patient experienced severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab test and procedure which included body temperature and result was shown as 99-101.2 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE; ALEVE

Current Illness:

ID: 1673835
Sex: M
Age:
State: FL

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Chills; Fever; Body aches and and pain all over; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 01:15 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The medical history included diabetes and heart condition. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient received medications( reported as too many to list) within two weeks of vaccination. The patient previously took prochlorperazine (COMPAZINE) on an unknown date and experienced allergy. On 20Apr2021 at 01:00, the patient experienced chills, fever, pain at injection site, body aches and pain all over. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, pain at injection site, body aches and pain all over were recovered un an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673836
Sex: F
Age:
State: GA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: This is a spontaneous report from a contactable physician, the patient. A forty-two-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 (at the age of 42-years-old) as a single dose. Medical history included uterine bleeding, Hodgkin's lymphoma x 3 status post autologous bone marrow transplant, anemia, gastric sleeve surgery, chronic rhinitis, high Thyroid Stimulating Hormone (TSH). The patient had no allergies to medications, food, or other products. Concomitant medications included levothyroxine sodium (SYNTHROID), norethendrone (MANUFACTURER UNKNOWN) and ferrous fumarate (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient had itchy rash on neck and skin peeling on face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included self-treatment with steroid cream (fluocinonide). The clinical outcome of the events itchy rash on neck and skin peeling on face were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; NORETHINDRONE [NORETHISTERONE ACETATE]; FERROUS FUMARATE

Current Illness:

ID: 1673837
Sex: F
Age:
State: VA

Vax Date: 04/15/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Vertigo started on April 20th; Tinnitus started on April 18th; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 20:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulfonamide allergy to sulfa drugs and seasonal allergy. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 14:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 13:15, the patient experienced tinnitus and vertigo started on 20Apr2021. Therapeutic measures were taken as a result of events and included treatment with unspecified exams and prescription for meclizine. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in emergency room/department or urgent care. The clinical outcome of the events tinnitus started on 18Apr2021 and vertigo started on 20Apr2021 were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LORATADINE

Current Illness:

ID: 1673838
Sex: U
Age:
State: OH

Vax Date: 03/26/2021
Onset Date: 04/02/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Ipsilateral left side clavicular lymphadenopathy; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 09:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and hypothyroidism. The patient had known allergies to sulfa. Concomitant medications included escitalopram oxalate (LEXAPRO) and levothyroxine sodium (SYNTHROID); both taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 02Apr2021 at 09:00, the patient experienced ipsilateral left side clavicular lymphadenopathy. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ipsilateral left side clavicular lymphadenopathy was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; SYNTHROID

Current Illness:

ID: 1673839
Sex: F
Age:
State: NY

Vax Date: 04/15/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration on 15Apr2021 at 09:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known drug allergy (NKDA). The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 the patient experienced left supraclavicular lymphadenopathy. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event left supraclavicular lymphadenopathy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673840
Sex: F
Age:
State: VA

Vax Date: 04/04/2021
Onset Date: 04/06/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 04Apr2021 at 14:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks prior to the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 04:30, the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673841
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Vertigo; Pain in right side of stomach; Dizziness; Arm pain (now subsided); This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had some known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 16Apr2021 at 12:00, the patient experienced vertigo, dizziness, arm pain (now subsided) and pain in right side of stomach. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of event arm pain, vertigo, dizziness and pain in right side of stomach were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673842
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: left forearm / Area was swollen, red and hot / visible patch on left forearm; left forearm / Area was swollen, red and hot / visible patch on left forearm; left forearm / Area was swollen, red and hot / Right forearm was also hot and irritated; Right forearm was also hot and irritated; This is a spontaneous report from a contactable healthcare professional, the patient. A 42-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. It was unknown if the patient was pregnant. The patient had allergy to chicken meat and buckwheat. Concomitant medications included montelukast sodium (SINGULAIR), taken for an unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. On 19Apr2021 at 09:00, 6 days post vaccination, the patient experienced delayed reaction on the left forearm, the area was swollen, red and hot. The right forearm was also hot and irritated but did not have a visible patch like left forearm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events left forearm area was swollen, red and hot with a visible patch and right forearm was hot and irritated were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SINGULAIR

Current Illness:

ID: 1673843
Sex: M
Age:
State: WI

Vax Date: 04/09/2021
Onset Date: 04/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Slight sore throat; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient experienced slight sore throat for over 7 days now (at the time of report). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event slight sore throat was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673844
Sex: M
Age:
State: IL

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Burning sensation in lower legs/ Burning legs; Pins and needles in feet/ Paresthesia in arms; Like a sunburn; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 21Apr2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8370) via an unspecified route of administration in the right arm on 29Mar2021 at 16:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 21Apr2021 at 13:00, the patient experienced pins and needles in feet, burning sensation in lower legs, like a sunburn, paraesthesia in arms and burning legs. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcomes of event pins and needles in feet, burning sensation in lower legs, like a sunburn, paraesthesia in arms and burning legs were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL

Current Illness:

ID: 1673845
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 04/09/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Mild case of shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 09:15 (at the age of 45-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included ulcerative colitis. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 09:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccination. On 09Apr2021, the patient experienced a mild case of shingles 2 weeks after the second vaccine. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild case of shingles was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673846
Sex: F
Age:
State: WA

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Throat constriction & scratchiness; Throat constriction & scratchiness; over heating; dizziness; itching of head, face, arms; This is a spontaneous report from a contactable consumer (patient). A 40 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8736), via an unspecified route, administered in Left Arm on 20Apr2021 at 13:15 (40-year-old at vaccination) as a dose 1, single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient had known allergies (too many to list in this space). The patient's concomitant medications included hydroxyzine; methylprednisolone (MEDROL); famotidine (PEPCID) and more than space allowed within in two weeks. The patient previously took polyethylene glycol compound and experienced known allergy to PEG. Facility type vaccination was reported as Hospital. The patient had not received any other vaccine in four weeks prior to vaccination. The patient was not diagnosed with Covid prior to vaccination. Since vaccination the patient was not tested for Covid. On 20Ap2021, the patient experienced throat constriction and scratchiness, overheating, dizziness, itching of head, face, arms. The patient was administered with epinephrine, steroids and transported by ambulance to ER. She had a known allergy to PEG and was premedicated by her allergist trying to avoid or at least lessen a reaction. The outcome of the events was recovering. No follow-up attempts are possible. No further information was expected.

Other Meds: HYDROXYZINE; MEDROL [METHYLPREDNISOLONE]; PEPCID [FAMOTIDINE]

Current Illness:

ID: 1673847
Sex: F
Age:
State: PA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: horrible sore throat with white spots & red, like strep throat; horrible sore throat with white spots & red, like strep throat; Sore on side of tongue; tired/ fatigue; no energy; body aches; pain in opposite right arm; itching in opposite right arm/ Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; This is a spontaneous report from a contactable Other-HCP (patient). A 59-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 17Mar2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, known allergies: Penicillin and shellfish. The patient's concomitant medications were not reported. The patient previously took Aleve, Novocaine and septocaine and experienced known allergies. The patient was not pregnant at time of vaccination. Th patient was not received other vaccine in four weeks. The patient was not received covid prior vaccination. The patient has not been tested covid post vaccination. On 17Mar2021, after first dose, the patient had horrible sore throat with white spots & red, like strep throat. The patient had Sore on side of tongue, gone in 2 days. Tired, no energy, fatigue, body aches through out. On an unknown date in Mar2021 (1 week later), the patient had pain, itching in opposite right arm exactly where shot was given in left arm. Redness and slight swelling, itchiness at first injection. The patient did not receive treatment for all events. The outcome of the event of Sore on side of tongue was recovered on 19Mar2021 and other events was recovering. The lot number for the vaccine, bnt162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1673848
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Numbness and tingling in arms and legs; Started with dead arm immediately after shot. Moved to left leg, then other side of the body a few days later.; Numbness and tingling in arms and legs.; Rapid heart rate; Palpitations; Inability to sleep.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced numbness and tingling in arms and legs, started with dead arm immediately after the shot. It moved to left leg and On an unknown date of Apr2021, a few days later, it moved to other side of the body. The patient also experienced rapid heart rate and palpitations and inability to sleep. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events- numbness and tingling in arms and legs, started with dead arm immediately after the shot and then moved to left leg, moved to the other side of the body, rapid heart rate, palpitations and inability to sleep was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673849
Sex: F
Age:
State: GA

Vax Date: 04/13/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Facial swelling; Redness and hot to touch on left side of face only.; Hot to touch on left side of face only.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included bipolar disorder and penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lithium (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 23mar2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. On 18Apr2021 at 04:00, the patient experienced facial swelling accompanied with redness and hot to touch on left side of face only. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events facial swelling accompanied with redness and hot to touch on left side of face only were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LITHIUM; GABAPENTIN; PROZAC

Current Illness:

ID: 1673850
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210410; Test Name: COVID-19 test; Test Result: Negative; Comments: Nasal Swab.

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Constant headaches which change from severe to moderate to dull/ Constanly delaing with headaches nonstop headaches located in the front of my forehead/become super difficult to deal with constant headaches.; Since taking the vaccine I have had constant headaches which change from severe to moderate, to dull but never go away They are constant and I now have had nose bleeds as well; Constanly delaing with headaches nonstop headaches located in the front of my forehead along with a feeling of heavy eyes.; I have also experienced some insomnia; Constantly tired and fatigued.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E18982) via an unspecified route of administration in the arm left on 25Feb2021 at 13:15 (at the age of 36-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 19Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included Diabetes, Sjogren's syndrome. The patient previously had penicillin for unknown indication on unknown date and experienced penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy (reported as: intervenes ibuprofen forget the name it starts with a t). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Feb2021 at 16:00, since taking the vaccine patient had constant headaches which change from severe to moderate to dull but never went away. They were constant and then patient had nose bleed as well. The patient was constantly dealing with headaches nonstop headaches located in the front of the forehead along with a feeling of heavy eyes. The patient was constantly tired and fatigued. The patient had also experienced some insomnia. It had become super difficult for the patient to deal with constant headaches. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 10Apr2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events since taking the vaccine had constant headaches which change from severe to moderate to dull but never went away; they were constant and then patient had nose bleed as well; was constantly dealing with headaches nonstop headaches located in the front of the forehead along with a feeling of heavy eyes; the patient was constantly tired and fatigued; had also experienced some insomnia; it had become super difficult to deal with constant headaches was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673851
Sex: F
Age:
State: CA

Vax Date: 03/29/2021
Onset Date: 04/08/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: I have shingles and I have never had it before; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 29Mar2021 at 13:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:00, the patient experienced shingles which the patient never had before. The adverse event resulted in emergency room/department or urgent care. The patient received antibiotic (unspecified) as treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673852
Sex: M
Age:
State: SC

Vax Date: 04/13/2021
Onset Date: 04/15/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Multiple fever blisters; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 02:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. On 15Apr2021, the patient experienced multiple fever blisters. The patient did not have a fever blister in 20 years or more. He had three since the shot. No therapeutic measures were taken for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the multiple fever blisters was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM

Current Illness:

ID: 1673853
Sex: M
Age:
State: MA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Developed a very itchy rash on my back. It was about the size of my fist and lasted 3 days; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Apr2021 at 12:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, ragweed allergy (allergy to plants) and somewhat allergic to bee sting. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient developed a very itchy rash on the back. It was about the size of the patient's fist and lasted 3 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy rash on the back was resolved 13Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1673854
Sex: F
Age:
State: FL

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: pain all over the body; coughing; sore throat; fever; soreness on site; Headaches; This is a spontaneous report from a contactable healthcare professional, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 26Mar2021 at 16:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did receive regular medicines within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 05:00, the patient experienced headaches, fever, pain all over the body, soreness on site, coughing and sore throat. The patient was in bed for four days. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headaches, fever, pain all over the body, soreness on site, coughing and sore throat was resolved on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673855
Sex: F
Age:
State: VA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Heart Rate; Result Unstructured Data: Test Result:112 Units:{DF}; Comments: 112 bpm rapid pulse (ave. 112 bpm)

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Muscle pain; Joint pain; Chills; Tiredness; Rapid pulse; Feeling unwell; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 21Apr2021 at 13:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included prior stroke, complex post-traumatic stress disorder (PTSD) and degenerative disc disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient received other medications within two weeks of the COVID-19 vaccine, names were unspecified. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 31Mar2021 at 13:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient previously took azithromycin (MANUFACTURER UNKNOWN), amoxicillin; clavulanate potassium (AUGMENTIN), guaifenesin (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication and experienced drug allergy. On 22Apr2021 at 01:00, the patient experienced muscle pain, joint pain, chills, tiredness, rapid pulse; Ave. 112 bpm, feeling unwell, fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. On 22Apr2021, the patient underwent heart rate and the result was 112 bpm. The clinical outcome of the events muscle pain, joint pain, chills, tiredness, rapid pulse; Ave. 112 bpm, feeling unwell, fever was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673856
Sex: M
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/03/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Itching sensation across body, no visible rash; Irritation on skin was present after physical scratching; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 01Apr2021 at 14:00 (at the age of 37 years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks prior to the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 08:00, the patient had an itching sensation across the body with no visible rash but irritation on skin was present after physical scratching. The symptom emerged within 48 hours of vaccine and still persisted (at the time of reporting) but had become milder. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itching sensation across the body with no visible rash, irritation on skin present after physical scratching was resolved with lasting effects on an unspecified date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673857
Sex: F
Age:
State: MA

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Joint aches; soreness in arm; stomach cramps; skin sensitivity; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 20Apr2021 at 12:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to food, medication or other products. Prior to the vaccination, the patient was not diagnosed with COVID. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955) via an unspecified route of administration in the right arm on 30Mar2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 14:30, the patient experienced joint aches, soreness in arm, stomach cramps and skin sensitivity. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event joint aches, soreness in arm, stomach cramps and skin sensitivity were recovered on an unknown date in Apr2021. No follow-up attempts are needed; No further information is expected.

Other Meds:

Current Illness:

ID: 1673858
Sex: F
Age:
State: KS

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Very sore bruised arm at the injection site; Slight cough; Sneezing; Runny nose; Feeling like a cold is coming; Weird feeling in head/ears; Tired; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included post-operative hypothyroidism, fibromyalgia, depression, anxiety and migraines. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 31Mar2021 at 10:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient previously took codeine (MANUFACTURER UNKNOWN) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy. On 22Apr2021 at 06:00, the patient experienced very sore bruised arm at the injection site, a slight cough, sneezing, runny nose, felt like a cold was coming (that weird feeling one gets in head/ears) and was a little extra tired but had no fever till the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore bruised arm at the injection site, slight cough, sneezing, runny nose, felt like a cold was coming (weird feeling in head/ears) and tired were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673859
Sex: F
Age:
State: OH

Vax Date: 04/11/2021
Onset Date: 04/14/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Delayed rash (hives) stomach, legs, back of arms, back and buttocks; Delayed rash (hives) stomach, legs, back of arms, back and buttocks; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 11Apr2021 at 16:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included pcos (polycystic ovarian syndrome) and high blood pressure. The patient had known allergies to sulfa, tea tree oil and detergent. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Mar2021 at 16:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 14Apr2021 at 08:00, the patient experienced delayed rash (hives) on stomach, legs, back of arms, back and buttocks. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported event which included treatment with a round of prednisone (MANUFACTURER UNKNOWN) of 40mg. The clinical outcome of events delayed rash (hives) on stomach, legs, back of arms, back and buttocks was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673860
Sex: F
Age:
State: PA

Vax Date: 03/26/2021
Onset Date: 04/10/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Shingles on the right side of her back and stomach; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 26Mar2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergies to some unspecified antibiotics. Concomitant medications included caffeine, paracetamol (EXCEDRIN) and ibuprofen (MOTRIN) all were from unknown date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 10Apr2021, the patient had shingles on the right side of her back and stomach. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with valacyclovir . The clinical outcome of the event shingles on the right side of her back and stomach was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: EXCEDRIN [CAFFEINE;PARACETAMOL]; MOTRIN [IBUPROFEN]

Current Illness:

ID: 1673861
Sex: M
Age:
State: KS

Vax Date: 04/19/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: I felt dizzy, the lights and furniture were swinging/spinning. I felt my brain physically rolled/moved inside my head.; I felt dizzy, the lights and furniture were swinging/spinning./ I felt my brain physically rolled/moved inside my head.; My mouth seemed num/tongue was not following his brain; My jaw was slow. Just not normal.; But the adverse effects on 04/21 night really worries me.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 11:15 (at the age of 57-year -old) as a single dose for COVID-19 immunisation. Medical history included colon (Unspecified disorder of intestine). The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 02:00, first time ever, at night in bed after midnight, when the patient moved the head felt dizzy, the lights and furniture were swinging/spinning. The patient felt that the brain physically rolled/moved inside the head. The patient woke his wife (multiple times) and his mouth seemed num. This occurred multiple times. The patient tried multiple times to see if it was his illusion (The patient really wished it was). The patient tested multiple times; it was really true (The patient was an engineer). In the early morning, when the patient made a phone call, he still felt that the tongue was not following his brain. The patient jaw was slow. Just not normal. The patient got the second shot on 19Apr2021, this side effect occurred at the night of 21Apr2021. The patient had relatively severe adverse effect on the first night 19Apr2021 after the second shot "(but it was fine I guess)", but the adverse effects on 21Apr2021 night really worries. The patient didn't have much feeling on the first shot though. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head felt dizzy, the lights and furniture were swinging/spinning, brain physically rolled/moved inside the head, mouth seemed num, tongue was not following brain and jaw slow were unknown at the time of this report No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673862
Sex: F
Age:
State: PA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Migraine started about a minute after the shot; Immediate tension to neck; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 14:15 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any medications within two weeks of vaccination. On 23Mar2021 at 14:15, the patient had immediate tension to her neck and about a minute after the shot, the patient experienced migraine. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any treatment for the reported events. The clinical outcome of the events immediate tension to neck and migraine was recovered on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:15 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673863
Sex: F
Age:
State: NC

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: This happened twice: 36 hours after the second vaccine and subsided after about 48 hours. It occurred again in April 14 and remains swollen and painful as of 4/22; Swelling in left arm pit lymph nodes; Pain and swelling in arm pit; Swelling in armpit, shoulder blade, and side; Pain and swelling in armpit, shoulder blade, and side; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8375) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included pneumonia in Jan2021. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG62R) via an unspecified route of administration in the arm left on 01Mar2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 20:00, the patient experienced swelling in left arm pit lymph nodes that caused pain and swelling in arm pit, shoulder blade, and side. This happened twice, 36 hours after the second vaccine and subsided after about 48 hours. It occurred again on 14Apr2021 and remained swollen as of 22Apr2021, the day of reporting. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with anti-inflammatory medications and hot compress. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in left arm pit lymph nodes that caused pain and swelling in arm pit, shoulder blade, and side was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673864
Sex: M
Age:
State: OH

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210420; Test Name: Body temperature; Result Unstructured Data: Test Result:100 degrees; Comments: Ran a slight fever, just hitting 100 degrees

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Headache; Stuffy nose; Throat was sore and dry; Throat was sore and dry; Arm was sore; Ran a slight fever, just hitting 100 degrees; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 19Apr2021 at 10:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and allergy to nuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included fexofenadine hydrochloride (ALLEGRA) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, day after vaccination, the patient's arm was sore and ran a slight fever, just hitting 100 degrees. The next day on 21Apr2021, the patient had a stuffy nose and throat was sore and dry. On 22Apr2021 (the day after 21Apr2021), the patient's nose was still stuffy, throat was still dry, and had a headache and slight fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm was sore, ran a slight fever, just hitting 100 degrees, stuffy nose, throat was sore and dry and headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1673865
Sex: F
Age:
State: NY

Vax Date: 04/18/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Red skin; mottled skin on left (more) and right (less) shin; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 18Apr2021 at 11:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, obstructive sleep apnea and penicillin allergy. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and octinoxate, octocrilene (SOLARIS); all taken on an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 28Mar2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 09:00, the patient experienced red skin, mottled skin on left (more) and right (less) shin, not itchy. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red skin, mottled skin on left (more) and right (less) shin was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: AMLODIPINE; LOSARTAN; HYDROCHLOROTHIAZIDE; SOLARIS

Current Illness:

ID: 1673866
Sex: F
Age:
State: OH

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Disorientation; Body aches; Brain fog; Sweats; Joint pain (especially in knees and lower back); Mild headache; Nausea; Chills; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 21Apr2021 at 10:15 hours in the left arm (at an age of 19-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. The medical history of the patient included dairy allergy. The patient received ethinylestradiol, norethisterone acetate (JUNEL FE 24) within 2 weeks of COVID-19 vaccine for birth control. The patient did not receive any other vaccination within 4 weeks of vaccination. Previously, the patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 31Mar2021 at 10:15 hours in the left arm as single dose for COVID-19 immunisation. On 21Apr2021, 9 hours post vaccination, at 21:15 hours, the patient had chills, sweats, body aches and joint pain (especially in knees and lower back), brain fog or disorientation (possibly due to headache), mild headache and nausea and were still ongoing. It was 24 hours post second vaccination at the time of this report. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of chills, sweats, body aches and joint pain (especially in knees and lower back), brain fog or disorientation, mild headache and nausea were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: JUNEL FE 24

Current Illness:

ID: 1673867
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Swollen and itchy left eye; Swollen and itchy left eye; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 29-years-old) as single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccination within 4 weeks of COVID vaccine. Concomitant medications included ethinylestradiol; ferrous fumarate; norethisterone acetate (JUNEL FE) from an unknown date for an unknown indication and unknown if ongoing. On 20Apr2021 at 15:00, the patient experienced swollen and itchy left eye. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of swollen and itchy left eye and included treatment with Benadryl and antibacterial cream. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events swollen and itchy left eye was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL FE

Current Illness:

ID: 1673868
Sex: M
Age:
State: NY

Vax Date: 03/13/2021
Onset Date: 03/15/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Anal wart outbreak after receiving 1st vaccine.; This is a spontaneous report from a contactable consumer. A male patient of 64-year-old age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was EN6202), first dose on right arm via an unspecified route of administration on 13-MAR-2021 10:15 at unknown DOSE 1, SINGLE for COVID-19 immunization. He received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was ER2613), on left arm via an unspecified route of administration on 03Apr2021, 10:15 for COVID-19 immunization. No medical history reported. Concomitant medication included Multivitamin Allegra (received within 2 weeks of vaccination). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. On 15Mar2021 patient experienced Anal wart outbreak after receiving 1st vaccine. The outcome of Event was not recovered. No follow up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1673869
Sex: M
Age:
State: NJ

Vax Date: 04/12/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: 5 days following the 2nd shot I experienced a sudden outbreak of hives on my torso, armpits and groin. The hives settled but returned suddenly the following day, but less severe. A small outbreak occurred late in the 3rd day.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 17:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration in the left arm on 17Mar2021 at 17:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 18:30, five days following the second shot, the patient experienced a sudden outbreak of hives on his torso, armpits and groin. The hives settled but returned suddenly the following day, but less severe. A small outbreak occurred late in the third day. None had occurred since. Therapeutic measures were taken as a result of a sudden outbreak of hives on his torso, armpits and groin and included treatment with Bendryl pills. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event five days following the second shot experienced a sudden outbreak of hives on torso, armpits and groin; the hives settled but returned suddenly the following day, but less severe; a small outbreak occurred late in the third day was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673870
Sex: F
Age:
State: MA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Flu like symptoms; This is a spontaneous report from a contactable consumer. An adult female patient of an unknown age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced flu like symptoms. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event flu like symptoms was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673871
Sex: F
Age:
State: MI

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Fever; Body pain; Vomiting; Chills; Headache; Hot flashes; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 21Apr2021 at 12:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, hypermobility, major depression and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included armodafinil (NUVIGIL), vortioxetine hydrobromide (TRINTELLIX), estradiol (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN) and midodrine (MANUFACTURER UNKNOWN); all for an unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 12:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation and previously received gabapentin (NEURONTIN) and dimenhydrinate (DRAMAMINE); both for an unknown indication from unknown date and experienced drug allergy. On 22Apr2021 at 04:30, the patient experienced fever, body pain, vomiting, chills, headache, hot flashes and injection site pain. The adverse events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever, body pain, vomiting, chills, headache, hot flashes and injection site pain was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: NUVIGIL; TRINTELLIX; ESTRADIOL; WELLBUTRIN; MIDODRINE

Current Illness:

ID: 1673872
Sex: F
Age:
State: ME

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Rash on face; Rash on both arms; itchiness; lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, seasonal allergy and allergic to sulfa and penicillin vk. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. On 22Apr2021 at 09:30, the patient experienced rash on both arms and face, accompanied by itchiness that lasted roughly 30 minutes and slight lightheadedness too. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on both arms and face, itchiness and lightheadedness were recovered on an unknown date in Apr2021 at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673873
Sex: F
Age:
State: PA

Vax Date: 03/30/2021
Onset Date: 04/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Diagnosed with shingles on 4/13, first noticed rash on stomach on April 11; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 at 16:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient was not allergic to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 08:00, twelve days after second dose of vaccination, the patient first noticed rash on stomach. On 13Apr2021, the patient was diagnosed with shingles. The patient had no other intervening health changes or issues between time of second vaccine and onset of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included treatment with valacyclovir 1 gram for 10 days. The clinical outcome of the event shingles was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673874
Sex: F
Age:
State: FL

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Itching Rash; This is a spontaneous report from a contactable nurse. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an intramuscular route of administration in the right arm on 01Apr2021 at 11:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included end stage renal disease (ESRD). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 02Apr2021, the patient experienced itching rash. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event which included treatment with antihistamine (unspecified) and cortisone cream (MANUFACTURER UNKNOWN). The clinical outcome of event itching rash was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673875
Sex: F
Age:
State: CT

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Weird bruise on arm for a week after the first shot; This is a spontaneous report from a contactable healthcare professional. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 25Mar2021 at 15:30 (at the age of 27-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), medroxyprogesterone acetate (DEPO PROVERA), gabapentin (MANUFACTURER UNKNOWN) and oxcarbazepine (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient had no known allergies. On 25Mar2021 at 15:30, the patient experienced weird bruise on her arm for a week after the first shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event weird bruise on arm for a week after the first shot was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; DEPO-PROVERA; GABAPENTIN; OXCARBAZEPINE

Current Illness:

ID: 1673876
Sex: F
Age:
State: TN

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Upset stomach; Slight fever; Headache; Tiredness; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8734) via an unspecified route of administration in the left arm on 21Apr2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pineapple and walnuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included citalopram hydrobromide (CELEXA), trazodone (MANUFACTURER UNKNOWN), loratadine (CLARITIN), fish oil (MANUFACTURER UNKNOWN) and unspecified birth control medication; all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 07:00, the patient experienced slight fever, headache, upset stomach, tiredness and sore arm. The events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events slight fever, headache, upset stomach, tiredness and sore arm were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; TRAZODONE; CLARITIN [LORATADINE]; FISH OIL

Current Illness:

ID: 1673877
Sex: M
Age:
State: OH

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Dizziness; Fever; Vomiting; Headache; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 21Apr2021 at 12:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via unspecified route of administration in the left arm on 31Mar2021 (at the age of 23-year-old) at 12:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:00 the patient experienced dizziness, fever, vomiting, headache, chills and fatigue. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events dizziness, fever, vomiting, headache, chills and fatigue were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673878
Sex: M
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Bad rash all over body; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 08:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Allergies to medications, food, or other products was reported as Not Applicable. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included hydrocodone (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), tamsulosin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 08:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 09:30, the patient experienced bad rash all over body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of bad rash all over body. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bad rash all over body was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: HYDROCODONE; IBUPROFEN; TAMSULOSIN; METOPROLOL

Current Illness:

ID: 1673879
Sex: F
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:100.1 Units:{DF}; Comments: at 04:00

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Sore throat; Sweats; 100.1 fever; Pain at injection sight; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 21Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included kato dietary supplement which was unspecified from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Apr2021 at 04:00, the patient experienced 100.1 (units unspecified) fever, sweats, pain at injection sight and sore throat. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events 100.1 (units unspecified) fever, sweats, pain at injection sight and sore throat was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am